Home | Endo
Endo’s century-long manufacturing legacy encompasses life-saving products and contributions to science and technology. The new 90,000-square-foot facility in Rochester, Michigan builds on this history and supports future innovations in medicine.
Investors | Endo - Press Releases
MALVERN, PA, December 20, 2024 – Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of...
Endo Receives U.S. FDA Approval of Manufacturing Facility in …
2024年12月9日 · 20,000-square-foot site increases Endo's sterile injectable production capacity; This marks the site's first U.S. FDA approval ; Endo is investing and innovating in its Injectable Solutions business
Endo Expands Voluntary Recall of Clonazepam Orally …
2024年11月18日 · Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating...
Focus Areas | Endo
Endo is boldly innovating in pursuit of transforming health and health system burdens. Through our long-standing work in endocrinology, orthopedics, and urology, as well as in hospital systems and with retail generic medications, we have developed an …
John Elway Teams Up with Endo to Share Update on Dupuytren's ...
MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment with XIAFLEX ® (collagenase clostridium histolyticum) five years ago.
Careers | Endo - Endo International
Discover more about Endo’s culture, our meaningful work, and the incredible people who deliver on our mission every day—in their own words.
History | Endo
Endo’s history can be traced back to the early 20th century and includes respected names in the science and pharmaceutical space, namely DuPont, Merck, and Parke-Davis.
Endo Launches Doxycycline for Injection, USP - Dec 10, 2024
2024年12月10日 · Endo, Inc. (OTCQX: NDOI) announced today that it has begun shipping doxycycline for injection, USP 100 mg/vial, an AP-rated version of DOXY 100™. "We're pleased to provide choices to healthcare...
Our Purpose | Endo
Discover more about Endo’s culture, our meaningful work, and the incredible people who deliver on our mission every day—in their own words.